Kenvue Inc. $KVUE Shares Sold by Hsbc Holdings PLC

Key Points

• Hsbc Holdings PLC reduced its stake in Kenvue Inc. by 3.7%, selling 124,921 shares and now holding approximately 3.24 million shares valued at $77.58 million.
• Kenvue reported $0.29 EPS for the latest quarter, slightly beating analysts' expectations, despite a 4% decline in revenue year-over-year, totaling $3.84 billion.
• The company announced a quarterly dividend increase to $0.2075 per share, with a yield of 3.8%, reflecting strong management commitment to returning value to shareholders.

Hsbc Holdings PLC trimmed its stake in Kenvue Inc. (NYSE:KVUE - Free Report) by 3.7% during the first quarter, according to its most recent 13F filing with the SEC. The firm owned 3,244,785 shares of the company's stock after selling 124,921 shares during the period. Hsbc Holdings PLC owned about 0.17% of Kenvue worth $77,576,000 as of its most recent filing with the SEC.

Other large investors have also recently added to or reduced their stakes in the company. Pittenger & Anderson Inc. purchased a new stake in Kenvue during the 1st quarter worth approximately $30,000. TruNorth Capital Management LLC purchased a new stake in Kenvue during the 1st quarter worth approximately $36,000. Clal Insurance Enterprises Holdings Ltd increased its stake in Kenvue by 378.5% during the 1st quarter. Clal Insurance Enterprises Holdings Ltd now owns 1,627 shares of the company's stock worth $39,000 after buying an additional 1,287 shares during the period. Bank Julius Baer & Co. Ltd Zurich increased its stake in Kenvue by 120.6% during the 1st quarter. Bank Julius Baer & Co. Ltd Zurich now owns 1,699 shares of the company's stock worth $41,000 after buying an additional 929 shares during the period. Finally, Clarity Asset Management Inc. purchased a new stake in Kenvue during the 4th quarter worth approximately $45,000. 97.64% of the stock is owned by hedge funds and other institutional investors.

Analyst Ratings Changes

Several equities research analysts recently weighed in on the stock. Canaccord Genuity Group cut their target price on shares of Kenvue from $29.00 to $26.00 and set a "buy" rating on the stock in a research note on Friday, August 8th. Bank of America lowered their price target on shares of Kenvue from $27.00 to $25.00 and set a "buy" rating for the company in a report on Tuesday, July 15th. Barclays lowered their price target on shares of Kenvue from $23.00 to $22.00 and set an "equal weight" rating for the company in a report on Tuesday, July 15th. Royal Bank Of Canada lowered their price target on shares of Kenvue from $24.00 to $22.00 and set a "sector perform" rating for the company in a report on Friday, August 8th. Finally, Zacks Research upgraded shares of Kenvue to a "strong sell" rating in a report on Monday, August 11th. Five research analysts have rated the stock with a Buy rating, seven have given a Hold rating and one has assigned a Sell rating to the company's stock. According to MarketBeat.com, the company presently has a consensus rating of "Hold" and a consensus price target of $24.38.

Kenvue Stock Up 0.7%

Shares of Kenvue stock traded up $0.1550 during trading hours on Friday, hitting $21.5950. The company had a trading volume of 8,620,226 shares, compared to its average volume of 18,631,350. The company's 50-day moving average is $21.52 and its two-hundred day moving average is $22.43. Kenvue Inc. has a twelve month low of $19.75 and a twelve month high of $25.17. The company has a debt-to-equity ratio of 0.66, a current ratio of 0.98 and a quick ratio of 0.68. The company has a market cap of $41.44 billion, a P/E ratio of 29.18, a price-to-earnings-growth ratio of 3.10 and a beta of 0.83.

Kenvue (NYSE:KVUE - Get Free Report) last issued its earnings results on Thursday, August 7th. The company reported $0.29 earnings per share (EPS) for the quarter, beating the consensus estimate of $0.28 by $0.01. Kenvue had a net margin of 9.37% and a return on equity of 20.06%. The business had revenue of $3.84 billion during the quarter, compared to analysts' expectations of $3.94 billion. During the same quarter in the prior year, the business posted $0.32 EPS. The company's revenue for the quarter was down 4.0% on a year-over-year basis. Kenvue has set its FY 2025 guidance at 1.000-1.050 EPS. Analysts anticipate that Kenvue Inc. will post 1.14 earnings per share for the current fiscal year.

Kenvue Increases Dividend

The firm also recently declared a quarterly dividend, which will be paid on Wednesday, August 27th. Investors of record on Wednesday, August 13th will be paid a dividend of $0.2075 per share. The ex-dividend date is Wednesday, August 13th. This represents a $0.83 dividend on an annualized basis and a yield of 3.8%. This is an increase from Kenvue's previous quarterly dividend of $0.21. Kenvue's dividend payout ratio (DPR) is currently 112.16%.

Kenvue Profile

Kenvue Inc operates as a consumer health company worldwide. The company operates through three segments: Self Care, Skin Health and Beauty, and Essential Health. The Self Care segment offers cough, cold and allergy, pain care, digestive health, smoking cessation, eye care, and other products under the Tylenol, Motrin, Benadryl, Nicorette, Zarbee's, ORSLTM, Rhinocort, Calpol, and Zyrtec brands.